← SynDRA
AVAGACESTAT
SynDRA canonical compound SYN0021639 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PSEN1 |
|---|
| Mechanism of action | gamma secretase inhibitor |
|---|
All known targets
- PSEN1
- APH1A
- APH1A; APH1B; NCSTN; PSENEN; PSEN1
- APH1B
- NCSTN
- PSEN2
- PSENEN
Mechanisms of action (all sources)
- APH1A INHIBITOR
- gamma-secretase inhibitor
- PSENEN INHIBITOR
- APH1B INHIBITOR
- PSEN1 INHIBITOR
- NCSTN INHIBITOR
- PSEN2 INHIBITOR
- Modulator
Drug classes
- Gamma Secretase Inhibitors and Modulators
Cross-references
Synonyms
- BMS-708163
- BMS-708163-01
- BMS-70816301
- BMS708163
- BMS 708163
- TQ44WWY45Q
- avagacestatum
- RefChem:115731
- DTXCID2073302
- Avagacestat (BMS-708163)
- BMS-708163 (Avagacestat)
- Avagacestat [USAN:INN]
- UNII-TQ44WWY45Q
- MFCD13195458
- Avagacestat [USAN]
- Avagacestat (USAN)
- C20H17ClF4N4O4S
- AVAGACESTAT [INN]
- AVAGACESTAT [WHO-DD]
- MLS006011074
- SCHEMBL310019
- Avagacestat; BMS-708163
- GTPL6489
- orb1300938
- SCHEMBL29392347
- Avagacestat, >=98% (HPLC)
- CHEBI:177493
- GLXC-03113
- HMS3884O07
- EX-A2871
- BDBM50458169
- NSC761217
- s1262
- AKOS005146523
- AKOS016016280
- CCG-269860
- CS-0180
- FA43361
Look up AVAGACESTAT in the interactive SynDRA portal →